Brian T. Powl Kura Oncology, Inc. (KURA) insider trading activity

KURA Quotes by TradingView

Brian T. Powl is Chief Commercial Officer of Kura Oncology, Inc.. Currently has a direct ownership of 59,667 shares of KURA, which is worth approximately $526,262. The most recent transaction as insider was on Jan 28, 2025, when has been sold 1,583 shares (Common Stock) at a price of $7.87 per share, resulting in proceeds of $12,458. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.7K
297.78% 3M change
297.78% 12M change
Total Value Held $526,262

Brian T. Powl Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 28 2025
SELL
Open market or private sale
$12,458 $7.87 p/Share
1,583 Reduced 2.58%
59,667 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
46,250 Added 43.02%
61,250 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock

Also insider at

FATE
FATE THERAPEUTICS INC Healthcare
Chief Commercial Officer
BTP

Brian T. Powl

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on KURA

Follow Kura Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KURA shares.

Notify only if

Insider Trading

Get notified when an Kura Oncology, Inc. insider buys or sells KURA shares.

Notify only if

News

Receive news related to Kura Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KURA